Ubro Yellow Milking Cow Intramammary Suspension

Ülke: Birleşik Krallık

Dil: İngilizce

Kaynak: VMD (Veterinary Medicines Directorate)

şimdi satın al

Indir Ürün özellikleri (SPC)
20-07-2021

Aktif bileşen:

Dihydrostreptomycin, Framycetin Sulphate, Penethamate hydriodide, non-micronised, Prednisolone

Mevcut itibaren:

Boehringer Ingelheim Animal Health UK Ltd

ATC kodu:

QJ51RV01

INN (International Adı):

Dihydrostreptomycin, Framycetin Sulphate, Penethamate hydriodide, non-micronised, Prednisolone

Farmasötik formu:

Intramammary suspension

Reçete türü:

POM-V - Prescription Only Medicine – Veterinarian

Terapötik grubu:

Cattle

Terapötik alanı:

Antimicrobial intramammary; Anti Inflammatory

Yetkilendirme durumu:

Expired

Yetkilendirme tarihi:

1985-03-29

Ürün özellikleri

                                Revised: November 2018
AN: 00957/2018
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF VETERINARY MEDICINAL PRODUCT
Ubro Yellow Milking Cow Intramammary Suspension
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 5ml injector contains the following active ingredients:
Penethamate Hydriodide
150 mg
Dihydrostreptomycin Sulphate
185 mg
(Equivalent to Dihydrostreptomycin 150mg)
Framycetin sulphate
50 mg
Prednisolone
5 mg
For a full list of excipients, see Section 6.1.
3.
PHARMACEUTICAL FORM
Intramammary suspension.
Opaque off-white suspension.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Bovine
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of mastitis caused by organisms sensitive to
penicillin,
streptomycin or framycetin in milking cows.
4.3
CONTRAINDICATIONS
None
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
During the course of treatment, the situation should be reviewed
frequently by close
veterinary supervision.
(I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Revised: November 2018
AN: 00957/2018
Page 2 of 4
Before infusion, the teats should be thoroughly cleansed ad
disinfected and care
should be taken to avoid contamination of the injector nozzle.
Following infusion it is
advisable to use teat dip or spray.
(II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMALS
Penicillins and cephalosporins may cause hypersensitivity (allergy)
following
injection, inhalation, ingestion or skin contact. Hypersensitivity to
penicillin may lead
to cross sensitivity to cephalosporins and vice versa. Allergic
reaction to these
substances may occasionally be serious.
1
Do not handle this product if you know you are sensitised, or if you
have been
advised not to work with such preparations.
2.
Handle this product with great care to avoid exposure, taking all
recommended precautions.
3.
If you develop symptoms following exposure such as a skin rash, you
should
seek medical advice and show the doctor this warning. Sw
                                
                                Belgenin tamamını okuyun